“Alternative vaccination platforms like Vaxxas’ patch technology can complement traditional needle ... Dr. Emini served as Director of the Bill & Melinda Gates global TB and HIV Programs. This was ...

This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...

However, most people get infected with TB don’t get sick, according to NCDHSS. That’s because their bodies can fight the ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

Tuberculosis is making headlines as the contagious respiratory disease spreads in the Midwest. Kansas is currently facing one ...

Introduction Possible Reasons for Failure of BCG TB Vaccines in Clinical Trials IL-17 as an Immune Correlate for Protective Vaccine-induced Responses Against TB References IL-17 as an Immune ...

People with latent or inactive TB cannot spread TB germs to others. There is a TB vaccine available, but due to low infection rates and the vaccine's loss of efficacy over time, it's not typically ...

J Gonzalo-Asensio and C Martin are co-inventors on a composition of matter patent 'tuberculosis vaccine' filed by the University of Zaragoza. The authors have no other relevant affiliations or ...

GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.